Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||
| DOI | 10.1177/21925682251339480 | ||
| Año | 2025 | ||
| Tipo | revisión |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Study Design: Systematic review. Objectives: The pre-symptomatic state of Degenerative Cervical Myelopathy (DCM), wherein degenerative changes and spinal cord compression are seen without clinical findings, is poorly understood and inconsistently categorised. Clear identification may elucidate the temporality of DCM development. Therefore, a systematic assessment was undertaken of current terminology for pre-DCM states, with the objective of standardising definitions and informing an AO Spine expert position statement. Methods: Medline and Embase were searched for all studies on asymptomatic spinal compression or clinical findings preceding DCM, returning 3585 studies. After screening, 96 studies were included in the final analysis. The terminology used for pre-DCM states and their definitions were extracted, along with their frequencies or speciality/country of author in the literature. Results Multiple terms were used to represent pre-DCM stages, including "asymptomatic" (86 studies), "non-myelopathic" (26 studies), "without myelopathy" (15 studies), "pre-symptomatic" (9 studies) and "sub-clinical" (7 studies). "asymptomatic" was associated with the greatest inconsistency. Some defined this as patients with radiological signs of spinal degeneration with/without spinal cord compression but no clinical signs of myelopathy, whereas others used the term synonymously with healthy controls. This inconsistency is particularly challenging in clinical studies in which DCM patients are compared to those with pre-DCM states and/or healthy volunteers. Conclusion: There is substantial inconsistency in the terms used to describe pre-DCM states. There is no clear relationship between the terms used and the country or speciality of the main author. Standardised definitions for these disease states should be agreed and used in future studies.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Agrawal, Vinisha | - |
UNIV CAMBRIDGE - Reino Unido
|
| 2 | Ali, Mohammed Farhan | - |
UNIV CAMBRIDGE - Reino Unido
|
| 3 | Yasin, Froher | - |
UNIV CAMBRIDGE - Reino Unido
|
| 4 | Ashraf, Daniyal | - |
UNIV CAMBRIDGE - Reino Unido
|
| 5 | Brannigan, Jamie F. M. | - |
UNIV CAMBRIDGE - Reino Unido
|
| 6 | Yurac, Ratko | - |
Universidad del Desarrollo - Chile
|
| 7 | Kumar, Vishal | - |
PGIMER - India
|
| 8 | Murphy, Rory | - |
Barrow Neurol Inst - Estados Unidos
|
| 9 | Tessitore, Enrico | - |
Univ Geneva - Suiza
|
| 10 | Molliqaj, Granit | - |
Univ Geneva - Suiza
|
| 11 | Dejaegher, Joost | - |
Katholieke Univ Leuven - Bélgica
|
| 12 | ZAMORANO-PEREZ, JUAN JOSE | Hombre |
Universidad del Desarrollo - Chile
Hosp Trabajador - Chile |
| 13 | Wynne-Jones, Guy | - |
Newcastle Upon Tyne Hosp NHS Fdn Trust - Reino Unido
|
| 14 | Tripathi, Manjul | - |
PGIMER - India
|
| 15 | Anderson, David B. | - |
UNIV SYDNEY - Australia
|
| 16 | Arbatin, Jose Joefrey F. | Hombre |
Chong Hua Hosp - Filipinas
|
| 17 | Kato, So | - |
Univ Tokyo Hosp - Japón
|
| 18 | Jayapalan, Ronie Romelean | - |
Univ Malaya - Malasia
|
| 19 | Dea, Nicolas | - |
UNIV BRITISH COLUMBIA - Canadá
|
| 20 | Harrop, James | Hombre |
Thomas Jefferson Univ - Estados Unidos
|
| 21 | Wilson, Jefferson | - |
UNIV TORONTO - Canadá
|
| 22 | Kwon, Brian K. | - |
UNIV BRITISH COLUMBIA - Canadá
|
| 23 | Martin, Allan R. | - |
UNIV CALIF DAVIS - Estados Unidos
|
| 24 | Bednarik, Josef | - |
Univ Hosp Brno - República Checa
Masaryk Univ - República Checa |
| 25 | Kotter, Mark R. | - |
UNIV CAMBRIDGE - Reino Unido
|
| 26 | Davies, Benjamin | - |
UNIV CAMBRIDGE - Reino Unido
|
| 27 | Mowforth, Oliver D. | - |
UNIV CAMBRIDGE - Reino Unido
|
| 28 | Nouri, Aria | - |
Univ Geneva - Suiza
UNIV CAMBRIDGE - Reino Unido |
| Fuente |
|---|
| Wellcome Trust |
| Ministry of Health of the Czech Republic |
| MRC |
| AO foundation |
| NIHR Clinician Scientist award |
| NIHR Academic Clinical Fellowship |
| NIHR Clinical Doctoral Fellowship |
| Year of Perfectioning Scholarship from Geneva University Hospitals |
| Agradecimiento |
|---|
| The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research aligns with the AO Spine RECODE-DCM top research priority Natural History selected by people living and working with DCM. For further information on how this process was conducted, why this question was prioritised, and global updates on currently aligned research, please visit aospine. org/recode/natural-history. The AO Spine RECODE-DCM Natural History Incubator, is supported by an award from the AO Foundation, administered through the AO Spine Spinal Cord Injury Knowledge Forum. This represents one, of a series of on-going initiatives to accelerate knowledge discovery, and its translation into practice, that can improve care. The initiative is now overseen by Myelopathy.org, an international charity for Degenerative Cervical Myelopathy. Research in the MK's laboratory is supported by a core support grant from the Wellcome Trust and MRC to the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute. MK is supported by a NIHR Clinician Scientist Award, CS-2015-15-023. BMD is supported by an NIHR Clinical Doctoral Fellowship. ODM is supported by an NIHR Academic Clinical Fellowship. AN is supported by the Year of Perfectioning Scholarship from Geneva University Hospitals. JB is supported by the Ministry of Health of the Czech Republic, grant nr. NU22-00024. |